** Shares of medical equipment maker Revvity RVTY.N rise 2% to $111 premarket
** Co forecasts 2026 adjusted profit per share of $5.35 to $5.45 vs analysts' average estimate of $5.32 - LSEG data
** RVTY reports Q4 adj. profit of $1.70/shr vs estimates of $1.55/shr
** Co's quarterly revenue of $772.1 million beats analysts' expectation of $761.3 million
** Up to last close, stock down 14.3% in last 12 months
(Reporting by Christy Santhosh)
((Christy.Santhosh@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.